Compared with patients taking non-GLP-1 diabetes medications, GLP-1 users had a 14% lower risk of developing any substance use disorder
Louis found that GLP-1 medications were associated with lower risks of developing substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other substances
Your doctor will then review the lab results with you to see if you would benefit from treatment with GLP-1s
Its a good reminder that if retatrutide becomes available, it would likely be used with regular medical check-ins with your provider to help keep things on track
The 2006 human study that Protandim quoted above is only a half-truth: yes, there was a 40% decrease in oxidative stress in study subjects using the TBARS test (which is not considered to be a reliable marker.) The methodology was also a mess
Both medications had similar gastrointestinal side effects